BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38296623)

  • 21. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
    Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
    Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma.
    Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S
    Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive analysis the prognostic and immune characteristics of mitochondrial transport-related gene SFXN1 in lung adenocarcinoma.
    Liu W; Du Q; Mei T; Wang J; Huang D; Qin T
    BMC Cancer; 2024 Jan; 24(1):94. PubMed ID: 38233752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor.
    Yu L; Qiao R; Xu J; Han B; Zhong R
    Life Sci; 2021 Mar; 268():119022. PubMed ID: 33434533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of radiotherapy-related autophagy genes in the prognosis and immune infiltration in lung adenocarcinoma.
    Gao J; Lu F; Yan J; Wang R; Xia Y; Wang L; Li L; Chang L; Li W
    Front Immunol; 2022; 13():992626. PubMed ID: 36311724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unlocking the role of EIF5A: A potential diagnostic marker regulating the cell cycle and showing negative correlation with immune infiltration in lung adenocarcinoma.
    Yang Z; Yuan H; He H; Qi S; Zhu X; Hu X; Jin M; Zhang XX; Yuan ZG
    Int Immunopharmacol; 2024 Jan; 126():111227. PubMed ID: 37977067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic and immunological potential of PPM1G in lung adenocarcinoma.
    Yin R; Qu L; Wang Z; Tang J; Gu H; Wang X; Yang D; Du P; Dong M
    Mol Med Rep; 2023 Aug; 28(2):. PubMed ID: 37387407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation.
    Li Z; Hu M; Qiu J; Feng J; Zhang R; Wu H; Hu G; Ren J
    Med Sci Monit; 2022 Jan; 28():e933447. PubMed ID: 35027526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
    Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
    Front Immunol; 2021; 12():724741. PubMed ID: 34335635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRAIP serves as a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma.
    Jing Y; Mao Z; Zhu J; Ma X; Liu H; Chen F
    Int Immunopharmacol; 2023 Sep; 122():110605. PubMed ID: 37451021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NPM3 as a novel oncogenic factor and poor prognostic marker contributes to cell proliferation and migration in lung adenocarcinoma.
    Wei S; Xing J; Lu K; Wang K; Yu W
    Hereditas; 2023 May; 160(1):27. PubMed ID: 37254219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated analyzes identify CCT3 as a modulator to shape immunosuppressive tumor microenvironment in lung adenocarcinoma.
    Huang J; Hu B; Yang Y; Liu H; Fan X; Zhou J; Chen L
    BMC Cancer; 2023 Mar; 23(1):241. PubMed ID: 36918801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
    Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y
    Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of CD80 as a Prognostic and Immunotherapeutic Biomarker in Lung Adenocarcinoma.
    Feng W; He Z; Shi L; Zhu Z; Ma H
    Biochem Genet; 2023 Oct; 61(5):1937-1966. PubMed ID: 36892747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.
    Wu Q; Li R; Wang QX; Zhang MY; Liu TT; Qu YQ
    J Transl Med; 2022 Jun; 20(1):260. PubMed ID: 35672776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TIMM17A overexpression in lung adenocarcinoma and its association with prognosis.
    Miao L; Wu D; Zhao H; Xie A
    Sci Rep; 2024 Apr; 14(1):8840. PubMed ID: 38632467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ferroptosis and WDFY4 as novel targets for immunotherapy of lung adenocarcinoma.
    Huang L; Zhong L; Cheng R; Chang L; Qin M; Liang H; Liao Z
    Aging (Albany NY); 2023 Sep; 15(18):9676-9694. PubMed ID: 37728413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (SND1) in human tumors.
    Cui X; Zhang X; Liu M; Zhao C; Zhang N; Ren Y; Su C; Zhang W; Sun X; He J; Gao X; Yang J
    Genomics; 2020 Nov; 112(6):3958-3967. PubMed ID: 32645525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SERPINB5 is a prognostic biomarker and promotes proliferation, metastasis and epithelial-mesenchymal transition (EMT) in lung adenocarcinoma.
    He X; Ma Y; Huang Z; Wang G; Wang W; Zhang R; Guo G; Zhang X; Wen Y; Zhang L
    Thorac Cancer; 2023 Aug; 14(23):2275-2287. PubMed ID: 37424293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Value and Genome Signature of m6A/m5C Regulated Genes in Early-Stage Lung Adenocarcinoma.
    Tian L; Wang Y; Tian J; Song W; Li L; Che G
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.